BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18267222)

  • 1. Quality of life after removal of left ventricular assist device for myocardial recovery.
    George RS; Yacoub MH; Bowles CT; Hipkin M; Rogers P; Hallas C; Banner NR; Dreyfus G; Khaghani A; Birks EJ
    J Heart Lung Transplant; 2008 Feb; 27(2):165-72. PubMed ID: 18267222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival after heart transplantation in patients with bridge to transplant in the recent era: a 17-year single-center experience.
    Osaki S; Edwards NM; Johnson MR; Velez M; Munoz A; Lozonschi L; Murray MA; Proebstle AK; Kohmoto T
    J Heart Lung Transplant; 2009 Jun; 28(6):591-7. PubMed ID: 19481020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric bridge to heart transplantation: application of the Berlin Heart, Medos and Thoratec ventricular assist devices.
    Arabía FA; Tsau PH; Smith RG; Nolan PE; Paramesh V; Bose RK; Woolley DS; Sethi GK; Rhenman BE; Copeland JG
    J Heart Lung Transplant; 2006 Jan; 25(1):16-21. PubMed ID: 16399525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices.
    Garatti A; Bruschi G; Colombo T; Russo C; Lanfranconi M; Milazzo F; Frigerio M; Vitali E
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):275-80; discussion 280. PubMed ID: 18375138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and outcomes after left ventricular assist device placement.
    Butler J; Howser R; Portner PM; Pierson RN
    Ann Thorac Surg; 2005 Jan; 79(1):66-73. PubMed ID: 15620917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes.
    Simon MA; Kormos RL; Murali S; Nair P; Heffernan M; Gorcsan J; Winowich S; McNamara DM
    Circulation; 2005 Aug; 112(9 Suppl):I32-6. PubMed ID: 16159839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study.
    Holman WL; Kormos RL; Naftel DC; Miller MA; Pagani FD; Blume E; Cleeton T; Koenig SC; Edwards L; Kirklin JK
    J Heart Lung Transplant; 2009 Jan; 28(1):44-50. PubMed ID: 19134530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional status and perceived control influence quality of life in female heart transplant recipients.
    Evangelista LS; Moser D; Dracup K; Doering L; Kobashigawa J
    J Heart Lung Transplant; 2004 Mar; 23(3):360-7. PubMed ID: 15019646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.
    Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W
    Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life after organ transplantation in type 1 diabetics with end-stage renal disease.
    Sureshkumar KK; Patel BM; Markatos A; Nghiem DD; Marcus RJ
    Clin Transplant; 2006; 20(1):19-25. PubMed ID: 16556148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life and psychological well-being during and after left ventricular assist device support.
    Wray J; Hallas CN; Banner NR
    Clin Transplant; 2007; 21(5):622-7. PubMed ID: 17845636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usage of the WHOQOL-100 as a trial of objective estimation of quality of life in end-stage renal disease patients treated with renal transplantation].
    Wesołowski T; Szyber P
    Pol Merkur Lekarski; 2004 Sep; 17(99):260-6. PubMed ID: 15628054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
    Teuteberg JJ; Ewald GA; Adamson RM; Lietz K; Miller LW; Tatooles AJ; Kormos RL; Sundareswaran KS; Farrar DJ; Rogers JG
    J Am Coll Cardiol; 2012 Jul; 60(1):44-51. PubMed ID: 22541834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.
    Pae WE; Connell JM; Adelowo A; Boehmer JP; Korfer R; El-Banayosy A; Hetzer R; Vigano M; Pavie A;
    J Heart Lung Transplant; 2007 Mar; 26(3):219-29. PubMed ID: 17346623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy.
    Esmore D; Kaye D; Spratt P; Larbalestier R; Ruygrok P; Tsui S; Meyers D; Fiane AE; Woodard J
    J Heart Lung Transplant; 2008 Jun; 27(6):579-88. PubMed ID: 18503955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.